Auxo Firm Directory · Independent Research Profile

Avesi Partners

Avesi Partners states that it invests in companies with $5-30mm of EBITDA and works with well-established management teams. Its stated strategy combines patient capital, aligned capital structures, organic growth, M&A, back-office efficiency, and revenue diversification.

Key takeaway

What stands out about Avesi Partners

Avesi Partners publicly describes a lower-middle-market private equity strategy centered on established management teams and companies with $5-30mm of EBITDA. Its stated sectors are healthcare services, healthcare technology, and business services.[1][2][3][5][12]

What does Avesi Partners invest in?

Avesi Partners describes itself as a private equity group that collaborates with lower-middle-market companies and well-established management teams. The firm identifies offices in Stamford, Connecticut, and Richmond, Virginia.[1][2]

Avesi states that its growth strategy includes partnering with established teams, establishing capital structures that align incentives, providing patient capital, and combining organic growth with M&A, back-office efficiency, and revenue diversification.

The firm also describes a thematic approach to investing and says it seeks to design and execute solutions to complex industry challenges in partnership with business owners and managers.[1][3]

Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.

Public size / criteria information

Avesi states that it invests in well-established management teams of companies with $5-30mm of EBITDA.[1]

What should a business owner evaluate before considering a transaction with Avesi Partners?

For an owner evaluating Avesi, the public information establishes a lower-middle-market focus, stated $5-30mm EBITDA criteria, sector focus in healthcare services, healthcare technology, and business services, and a partnership model involving established management teams, patient capital, aligned capital structures, organic growth, and M&A. An owner may wish to clarify the proposed ownership structure, management incentives, governance rights, financing approach, operating resources, follow-on acquisition capital, and intended investment horizon.[1][4][5][6][7][8][9]

How would the proposed capital structure align incentives between Avesi and the existing owners and management team

Avesi states that it establishes capital structures that align incentives and partners with established teams.[1]

What operating resources would be available to support organic growth, back-office efficiency, revenue diversification, and M&A

Avesi describes these activities as elements of its stated growth strategy.[1]

How does Avesi define patient capital, and what investment horizon would it expect for the proposed transaction

Avesi publicly uses the term “patient capital”; the specific investment horizon should be clarified directly.[1]

What companies does Avesi Partners target?

Avesi states that it invests in well-established management teams of companies with $5-30mm of EBITDA.[1]

Avesi identifies healthcare services, healthcare technology, and business services as its investment sectors. Its stated experience includes behavioral health, data analytics, hospital outsourcing, payment integrity, payor services, physical therapy, value-based care, cybersecurity, education, insurance services, marketing services, risk management, and wealth management.[4]

Avesi publicly identifies offices in Stamford, Connecticut, and Richmond, Virginia. The cited investment-approach page does not state a formal geographic investment mandate.[2][3]

Public announcements identify both direct investments by Avesi and acquisitions by portfolio companies. Avesi announced investments in Mosaic Consulting Group, First Steps Recovery, and Visante. Its portfolio company Point Quest separately announced acquisitions of Eleutheria and Nyman Associates.[5][6][7][8][9]

Avesi announced a strategic investment in Mosaic Consulting Group on October 2, 2025, stating that it partnered with the company’s leadership team to support organic and M&A-driven growth.

Avesi announced investments in First Steps Recovery on April 23, 2024, and Visante on February 12, 2024, and stated that it partnered with each company’s existing management team to support growth.[5][6][7]

Publicly identified transactions include Avesi’s announced strategic investment in Mosaic Consulting Group on October 2, 2025; its announced investment in First Steps Recovery on April 23, 2024; and its announced investment in Visante on February 12, 2024.

Portfolio-company activity includes Point Quest’s announced acquisition of Eleutheria on December 20, 2024, and announced acquisition of Nyman Associates on July 13, 2024.[5][6][7][8][9]

What is not clear from Avesi Partners's public investment criteria?

The cited Mosaic Consulting Group announcement does not disclose the transaction’s purchase price, valuation, ownership percentage, or financing terms.

The cited investment-approach page does not state a formal geographic investment mandate. The retrieved text of the cited portfolio page labels a Current Investments section but does not provide identifiable portfolio-company names in that page text.[3][5][12]

Questions to ask when evaluating Avesi Partners as a buyer or investment partner

How would the proposed capital structure align incentives between Avesi and the existing owners and management team?

Avesi states that it establishes capital structures that align incentives and partners with established teams.[1]

What operating resources would be available to support organic growth, back-office efficiency, revenue diversification, and M&A?

Avesi describes these activities as elements of its stated growth strategy.[1]

How does Avesi define patient capital, and what investment horizon would it expect for the proposed transaction?

Avesi publicly uses the term “patient capital”; the specific investment horizon should be clarified directly.[1]

What follow-on acquisition capital and support could be available for a platform company?

Avesi describes M&A as part of its growth strategy, and its public announcements identify acquisitions by portfolio company Point Quest.[1][8][9]

Which geographic markets would the firm consider for this company and its growth plan?

The cited investment-approach page does not state a formal geographic investment mandate.[3]

What purchase price, ownership structure, financing terms, and transaction expenses would apply to the proposed transaction?

The cited Mosaic Consulting Group announcement does not disclose purchase price, valuation, ownership percentage, or financing terms, making these items appropriate to clarify for a proposed transaction.[5]

Sources & research notes

Public-source research

Prepared and reviewed by: Auxo Capital AdvisorsEvidence standard: Public-source verification

How this profile was researched

Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.

Independent profile & regulatory context

Independent research profile

This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.

Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.

Broker-dealer and securities disclosure

Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.

Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.

Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.

Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.